Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

Inclusion Criteria: Documented symptomatic peripheral arterial disease (one or both of the following two primary criteria must be satisfied): * Current intermittent claudication with Ankle Brachial Index (ABI) \< 0.90 * A history of intermittent claudication together with previous related intervention in a leg Exclusion Criteria: * Patients who had acute atherothrombotic events or any invasive therapies within 30 days before the randomization, or patients who planned any invasive therapies within 12 weeks after the randomization * Bleeding diathesis, coagulopathy and present bleeding disease * Previous intracranial bleeding or hemorrhagic stroke * Uncontrolled hypertension The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.